BioInvent: New Clinical Trial Collaboration and Supply Agreement with MSD
Research Note
2024-04-03
10:41
Redeye is optimistic about the new agreement with MSD/Merck to provide Keytruda for the combination part of the phase I/IIa study of BI-1910.
RR
Richard Ramanius
Disclosures and disclaimers